News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tecan Systems Handle High Throughput Prediction of Cancer Recurrence


8/17/2007 11:51:47 AM

DURHAM, N.C.--(BUSINESS WIRE)--Researchers at the life sciences company Genomic Health Inc., California, have chosen Tecan’s liquid handling workstations to automate the development of their multi-gene expression assay that predicts the risk of recurrence of cancer and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES